A detailed history of Creative Planning transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Creative Planning holds 11,407 shares of DGX stock, worth $1.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,407
Previous 9,478 20.35%
Holding current value
$1.56 Million
Previous $1.26 Million 23.79%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$125.91 - $144.34 $242,880 - $278,431
1,929 Added 20.35%
11,407 $1.56 Million
Q1 2024

May 10, 2024

SELL
$123.78 - $142.11 $4,084 - $4,689
-33 Reduced 0.35%
9,478 $1.26 Million
Q4 2023

Feb 14, 2024

BUY
$120.62 - $141.12 $129,184 - $151,139
1,071 Added 12.69%
9,511 $1.31 Million
Q3 2023

Nov 16, 2023

SELL
$121.86 - $144.92 $52,156 - $62,025
-428 Reduced 4.83%
8,440 $1.03 Million
Q2 2023

Jul 21, 2023

BUY
$130.56 - $146.84 $45,434 - $51,100
348 Added 4.08%
8,868 $1.25 Million
Q1 2023

May 15, 2023

SELL
$131.53 - $155.76 $131,530 - $155,760
-1,000 Reduced 10.5%
8,520 $1.21 Million
Q4 2022

Feb 10, 2023

BUY
$123.31 - $157.26 $66,340 - $84,605
538 Added 5.99%
9,520 $1.49 Million
Q3 2022

Nov 03, 2022

BUY
$121.77 - $141.1 $31,294 - $36,262
257 Added 2.95%
8,982 $1.1 Million
Q2 2022

Aug 15, 2022

BUY
$127.07 - $145.39 $166,334 - $190,315
1,309 Added 17.65%
8,725 $1.16 Million
Q1 2022

May 16, 2022

BUY
$129.09 - $164.35 $1,032 - $1,314
8 Added 0.11%
7,416 $1.02 Million
Q4 2021

Feb 11, 2022

BUY
$140.36 - $173.01 $13,755 - $16,954
98 Added 1.34%
7,408 $1.28 Million
Q3 2021

Nov 10, 2021

BUY
$132.95 - $158.0 $38,688 - $45,978
291 Added 4.15%
7,310 $1.06 Million
Q2 2021

Aug 04, 2021

SELL
$126.66 - $141.48 $255,726 - $285,648
-2,019 Reduced 22.34%
7,019 $926,000
Q1 2021

Apr 30, 2021

BUY
$114.63 - $133.34 $24,530 - $28,534
214 Added 2.43%
9,038 $1.16 Million
Q4 2020

Jan 29, 2021

BUY
$112.7 - $128.05 $42,149 - $47,890
374 Added 4.43%
8,824 $1.05 Million
Q3 2020

Nov 05, 2020

SELL
$107.05 - $130.01 $57,807 - $70,205
-540 Reduced 6.01%
8,450 $967,000
Q2 2020

Jul 23, 2020

SELL
$73.34 - $122.61 $17,308 - $28,935
-236 Reduced 2.56%
8,990 $1.03 Million
Q1 2020

May 05, 2020

BUY
$75.14 - $115.68 $79,347 - $122,158
1,056 Added 12.93%
9,226 $741,000
Q4 2019

Jan 30, 2020

BUY
$100.29 - $107.99 $14,742 - $15,874
147 Added 1.83%
8,170 $872,000
Q3 2019

Nov 01, 2019

SELL
$97.85 - $107.42 $35,910 - $39,423
-367 Reduced 4.37%
8,023 $859,000
Q2 2019

Jul 26, 2019

BUY
$85.18 - $101.94 $182,114 - $217,947
2,138 Added 34.2%
8,390 $854,000
Q1 2019

Apr 24, 2019

SELL
$80.68 - $89.92 $24,607 - $27,425
-305 Reduced 4.65%
6,252 $562,000
Q4 2018

Feb 01, 2019

SELL
$79.75 - $108.38 $29,906 - $40,642
-375 Reduced 5.41%
6,557 $546,000
Q3 2018

Oct 25, 2018

BUY
$105.42 - $114.99 $162,873 - $177,659
1,545 Added 28.68%
6,932 $748,000
Q2 2018

Jul 20, 2018

BUY
$97.35 - $113.14 $32,417 - $37,675
333 Added 6.59%
5,387 $592,000
Q1 2018

Apr 18, 2018

SELL
$96.42 - $107.88 $84,946 - $95,042
-881 Reduced 14.84%
5,054 $507,000
Q4 2017

Jan 17, 2018

SELL
$90.86 - $100.24 $53,243 - $58,740
-586 Reduced 8.99%
5,935 $585,000
Q3 2017

Oct 17, 2017

BUY
$91.96 - $108.35 $599,671 - $706,550
6,521
6,521 $611,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.